[Use of proteolysis inhibitors for treating parainfluenza infections in an experiment and in the clinic].
D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D002648:Child; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D006801:Humans; D010224:Parainfluenza Virus 3, Human / Q000187:drug effects / Q000276:immunology / Q000502:physiology; D018184:Paramyxoviridae Infections / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D014764:Viral Proteins / Q000037:antagonists & inhibitors; D014779:Virus Replication / Q000187:drug effects
D000956:Antigens, Viral; D011480:Protease Inhibitors; D014764:Viral Proteins
Primenenie ingibitorov proteoliza dlia lecheniia paragrippoznykh infektsiĭ v éksperimente i klinike.